Forest Hill Health And Rehabilitation Center | |
109 Forest Valley Drive, Forest Hill, Maryland 21050 | |
(410) 838-0101 | |
Name | Forest Hill Health And Rehabilitation Center |
---|---|
Location | 109 Forest Valley Drive, Forest Hill, Maryland |
Certified By | Medicare and Medicaid |
No. of Certified Beds | 156 |
Occupancy Rate | 68.27% |
Medicare ID (CCN) | 215194 |
Legal Business Name | Ssc Forest Hill Operating Company Llc |
Ownership Type | For Profit - Corporation |
NPI Number | 1760503353 |
Organization Name | SSC FOREST HILL OPERATING COMPANY LLC |
Doing Business As | FOREST HILL HEALTH AND REHABILITATION CENTER |
Address | 109 Forest Valley Dr, Forest Hill, MD 21050 |
Phone Number | 410-893-2468 |
News Archive
People with the genetic blood clotting disorder hemophilia who have been infected with HIV for decades have an increased proportion of immune cells in their blood that specifically target HIV. This protective immune response helps chronically infected hemophilia patients survive, even during periods of HIV activity, according to a study published in BioResearch Open Access, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.
Volcano Corporation today announced the pricing of its offering of $100 million aggregate principal amount of 2.875 percent convertible senior notes due September 1, 2015 registered under the Securities Act of 1933, as amended. Prior to June 1, 2015, the notes will be convertible only upon certain circumstances.
Eisai Inc. today announced that the U.S. Food and Drug Administration has approved BANZEL Oral Suspension, 40 mg/mL, for the adjunctive treatment of seizures associated with Lennox-Gastaut syndrome in children 4 years and older and adults.
Japanese researchers centered at Nagoya University reveal a role for orexin neurons of the hypothalamus when mice respond to painful stimuli, and suggest a link between stimulus response and consciousness.
Zinc sulfate, a supplement thought to be helpful in regaining the sense of taste for some head and neck cancer patients after radiation therapy, has been found to have no significant impact on preventing or curing taste alteration, according to a study released today in the International Journal for Radiation Oncology-Biology-Physics, the official journal of ASTRO.
› Verified 8 days ago
Ratings from Surveys (Inspections): | |
Ratings from Quality Measures: | |
Ratings from Staffing Data: | |
Overall Rating: |
---|
News Archive
People with the genetic blood clotting disorder hemophilia who have been infected with HIV for decades have an increased proportion of immune cells in their blood that specifically target HIV. This protective immune response helps chronically infected hemophilia patients survive, even during periods of HIV activity, according to a study published in BioResearch Open Access, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.
Volcano Corporation today announced the pricing of its offering of $100 million aggregate principal amount of 2.875 percent convertible senior notes due September 1, 2015 registered under the Securities Act of 1933, as amended. Prior to June 1, 2015, the notes will be convertible only upon certain circumstances.
Eisai Inc. today announced that the U.S. Food and Drug Administration has approved BANZEL Oral Suspension, 40 mg/mL, for the adjunctive treatment of seizures associated with Lennox-Gastaut syndrome in children 4 years and older and adults.
Japanese researchers centered at Nagoya University reveal a role for orexin neurons of the hypothalamus when mice respond to painful stimuli, and suggest a link between stimulus response and consciousness.
Zinc sulfate, a supplement thought to be helpful in regaining the sense of taste for some head and neck cancer patients after radiation therapy, has been found to have no significant impact on preventing or curing taste alteration, according to a study released today in the International Journal for Radiation Oncology-Biology-Physics, the official journal of ASTRO.
› Verified 8 days ago
Number of Facility Reported Incidents | 0 |
Number of Substantiated Complaints | 0 |
Number of Fines | 0 |
Total Amount of Fines in Dollars | $0 |
Number of Payment Denials | 0 |
Total Number of Penalties | 0 |
Experience Measure | Provider | National Avg. |
---|---|---|
Percentage of long-stay residents whose need for help with daily activities has increased | 20.45 | 14.46 |
Percentage of long-stay residents who lose too much weight | 11.64 | 5.51 |
Percentage of low risk long-stay residents who lose control of their bowels or bladder | 70.21 | 48.41 |
Percentage of long-stay residents with a catheter inserted and left in their bladder | 0.45 | 1.79 |
Percentage of long-stay residents with a urinary tract infection | 1.25 | 2.65 |
Percentage of long-stay residents who have depressive symptoms | 11.45 | 5.05 |
Percentage of long-stay residents who were physically restrained | 0.85 | 0.23 |
Percentage of long-stay residents experiencing one or more falls with major injury | 2.25 | 3.36 |
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 98.59 | 93.87 |
Percentage of long-stay residents who received an antipsychotic medication | 12.39 | 14.2 |
Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 76.26 | 83.88 |
Percentage of short-stay residents who newly received an antipsychotic medication | 2.15 | 1.79 |
Percentage of long-stay residents whose ability to move independently worsened | 33.79 | 17.09 |
Percentage of long-stay residents who received an antianxiety or hypnotic medication | 19.77 | 19.7 |
Percentage of high risk long-stay residents with pressure ulcers | 6.99 | 7.32 |
Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 93.4 | 95.98 |
Percentage of short-stay residents who made improvements in function | 71.95 | 67.99 |
Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 69.84 | 82.93 |
News Archive
People with the genetic blood clotting disorder hemophilia who have been infected with HIV for decades have an increased proportion of immune cells in their blood that specifically target HIV. This protective immune response helps chronically infected hemophilia patients survive, even during periods of HIV activity, according to a study published in BioResearch Open Access, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.
Volcano Corporation today announced the pricing of its offering of $100 million aggregate principal amount of 2.875 percent convertible senior notes due September 1, 2015 registered under the Securities Act of 1933, as amended. Prior to June 1, 2015, the notes will be convertible only upon certain circumstances.
Eisai Inc. today announced that the U.S. Food and Drug Administration has approved BANZEL Oral Suspension, 40 mg/mL, for the adjunctive treatment of seizures associated with Lennox-Gastaut syndrome in children 4 years and older and adults.
Japanese researchers centered at Nagoya University reveal a role for orexin neurons of the hypothalamus when mice respond to painful stimuli, and suggest a link between stimulus response and consciousness.
Zinc sulfate, a supplement thought to be helpful in regaining the sense of taste for some head and neck cancer patients after radiation therapy, has been found to have no significant impact on preventing or curing taste alteration, according to a study released today in the International Journal for Radiation Oncology-Biology-Physics, the official journal of ASTRO.
› Verified 8 days ago
Forest Hill Health And Rehabilitation Center Location: 109 Forest Valley Drive, Forest Hill, Maryland 21050 Phone: (410) 838-0101 |